Get 40% Off
🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

Australia shares post 3-week closing highs on banks, iron ore miners

Published 11/08/2020, 04:56 pm
Updated 11/08/2020, 05:00 pm
© Reuters.
AXJO
-
BHP
-
CBA
-
RIO
-
JHX
-
MSB
-
NCM
-
RIO
-
AXGD
-
AXFJ
-
NST
-
NZ50
-

(Updates to close)

By Soumyajit Saha

Aug 11 (Reuters) - Australian shares rose to three-week closing highs on Tuesday, helped by gains in heavyweight financials and iron ore miners, while signs of steadying employment and improving business conditions added to investor confidence.

The S&P/ASX 200 index .AXJO settled 0.5% higher at 6,138.7, its highest close since July 21, in low-volume trading.

Leading the charge, financials .AXFJ rose more than 1%, with the 'big four' banks climbing in a range of 1% to 2.7%.

"Among banks there is clearly a little bit of short-covering taking place before Commonwealth Bank's CBA.AX results, along with indications that the economy might not be doing as terribly as previously feared," said Henry Jennings, market analyst at Marcus Today Financial.

Lifting investor sentiment, data showed Australian employment was steady through July, while a measure of business conditions also improved as the service sector rebounded. state of Victoria, which has been grappling with a fresh wave of coronavirus cases, reported a small rise in new infections, boosting hopes that case numbers are stabilising as a result of the lockdown measures. gainers, shares of some iron ore miners rose as futures on China's Dalian Commodity Exchange jumped on falling portside inventories and upbeat demand, with BHP Group BHP.AX and Rio Tinto (LON:RIO) RIO.AX gaining 0.9% each. stocks .AXGD fell over 4% as bullion prices retreated on a stronger dollar. GOL/

Newcrest Mining NCM.AX , the country's largest independent gold miner, lost 2.8%, while Northern Star Resources NST.AX dropped 5%.

Among individual stocks, building materials giant James Hardie Industries JHX.AX soared 8% on steady first-quarter earnings and forecasting a potential rise in full-year profit. firm Mesoblast MSB.AX dropped more than 30% after a U.S. FDA committee questioned the efficacy of one of its leading drug candidates. Zealand's benchmark S&P/NZX 50 index .NZ50 slipped 0.3% to 11,645.3, dragged by losses in healthcare and consumer stocks.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.